Esperance Pharmaceuticals
Latest round
- Series B
Last raised
- Jun 2011
Total raised
- $5.7M
Investors
- 7
About Esperance Pharmaceuticals
Founded in 2006 and based in Texas, US, Esperance Pharmaceuticals, Inc. develops therapeutics that can kill cancer cells without harming normal cells. The company offers EP-100, an anticancer drug for the treatment of ovarian cancer and breast cancer.
Who invested in Esperance Pharmaceuticals
7 investors across 1 round
See all investors in Esperance Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 1, 2011
Amount
$5.7M
Investors
Questions about Esperance Pharmaceuticals
Who invested in Esperance Pharmaceuticals?
Esperance Pharmaceuticals has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Esperance Pharmaceuticals raised?
Esperance Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Esperance Pharmaceuticals last raise money?
Esperance Pharmaceuticals's most recent round on record is a Series B, in Jun 2011.
What does Esperance Pharmaceuticals do?
Founded in 2006 and based in Texas, US, Esperance Pharmaceuticals, Inc.
Where is Esperance Pharmaceuticals headquartered?
Esperance Pharmaceuticals is headquartered in Houston, US.
Which VCs invest in companies like Esperance Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Esperance Pharmaceuticals's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Esperance Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.